CSIMarket Company Name, Ticker, Industry, else..
 
Stemline Therapeutics Inc  (STML)
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 48
 Employees -
 Revenues (TTM) (Millions $) 47
 Net Income (TTM) (Millions $) -71
 Cash Flow (TTM) (Millions $) 20
 Capital Exp. (TTM) (Millions $) 0

Business Description


Stemline Therapeutics Inc. is a biopharmaceutical company that specializes in the development and commercialization of novel oncology therapeutics. The company focuses on creating targeted therapies that address unmet medical needs in various types of cancer. Stemline Therapeutics is known for its pipeline of innovative drugs designed to target cancer stem cells and tumor bulk. Some of its notable products include Elzonris, a treatment for blastic plasmacytoid dendritic cell neoplasm, and SL-401, a treatment for certain blood cancers. The company aims to improve patient outcomes and make a significant impact on the field of cancer treatment through its ongoing research and development efforts.




   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
VBIV   -48.28%    
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 6.66
Working Capital Ratio 7.43
Leverage Ratio (MRQ) 0.16
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -1.63 $
Revenues (TTM) 0.99 $
Cash Flow (TTM) 0.42 $
Cash 3.18 $
Book Value 3.1 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -
Receivable Turnover Ratio (TTM) 3.21
Inventory Turnover Ratio (TTM) 2.41
Asset Turnover Ratio (TTM) 0.28

Profitability Ratios Current
Gross Margin (MRQ) 92.78 %
Operating Margin (MRQ) -246.3 %
Net Margin (MRQ) -239.99 %
Net Cash Flow Margin (MRQ) 176.6 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.